We are live on ! Find out more
INDP icon

Indaptus Therapeutics
INDP

5 hedge funds and large institutions have $3.23K invested in Indaptus Therapeutics in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.17% less ownership

Funds ownership: 0.17% → 0% (-0.17%)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

71% less funds holding

Funds holding: 17 → 5 (-12)

92% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 13

99% less capital invested

Capital invested by funds: $378K → $3.23K (-$375K)

Holders
5
Holders Change
-12
Holders Change %
-70.59%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
2
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
+$315
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$117

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$141K
2
IHL
Investment House LLC
California
-$70.9K
3
Geode Capital Management
Geode Capital Management
Massachusetts
-$68.7K
4
SAM
Strategy Asset Managers
California
-$24.9K
5
PVI
Pine Valley Investments
New Jersey
-$24.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
SS
1
SBI Securities
Japan
$1.64K -$12 -1 -0.6%
TRCT
2
Tower Research Capital (TRC)
New York
$1.14K -$198 -17 -14%
Bank of America
3
Bank of America
North Carolina
$327 +$315 +27 +675%
Fidelity Investments
4
Fidelity Investments
Massachusetts
$105 +$117 +10 New
Wells Fargo
5
Wells Fargo
California
$21 – – –
Vanguard Group
6
Vanguard Group
Pennsylvania
– -$141K -9,152 Closed
IHL
7
Investment House LLC
California
– -$70.9K -4,602 Closed
Geode Capital Management
8
Geode Capital Management
Massachusetts
– -$68.7K -4,463 Closed
SAM
9
Strategy Asset Managers
California
– -$24.9K -1,619 Closed
PVI
10
Pine Valley Investments
New Jersey
– -$24.1K -1,563 Closed
Renaissance Technologies
11
Renaissance Technologies
New York
– -$15.7K -1,018 Closed
VCM
12
Vivaldi Capital Management
Illinois
– -$13.2K -857 Closed
State Street
13
State Street
Massachusetts
– -$7.19K -467 Closed
VF
14
Virtu Financial
New York
– -$7K -460 Closed
Morgan Stanley
15
Morgan Stanley
New York
– -$486 -32 Closed
BSB
16
Bangor Savings Bank
Maine
– -$192 -13 Closed
UBS Group
17
UBS Group
Switzerland
– -$49 -3 Closed
JP Morgan Chase
18
JP Morgan Chase
New York
– -$9 -1 Closed
DB
19
Danske Bank
Denmark
– -$1 – –
Group One Trading
20
Group One Trading
Illinois
– -$4 – –

INDP Hedge Fund Activity: Q2 2025 in Review

5 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Indaptus Therapeutics (INDP) for Q2 2025, worth a combined $3.23K — down 99% from $378K a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of INDP and 1 opened new positions — a net loss of 12 holders — while 2 trimmed existing stakes and 1 added.

The largest buyer was Bank of America, adding an estimated $315. The largest seller was Vanguard Group, exiting entirely with an estimated $141K sold.

  • 5 institutional investors held Indaptus Therapeutics (INDP) as of Q2 2025, down from 17 in Q1 2025.
  • Funds reported $3.23K of Indaptus Therapeutics stock for Q2 2025, down 99% quarter-over-quarter.
  • 1 fund opened new Indaptus Therapeutics positions in Q2 2025 and 13 closed out, a net change of -12 holders.
  • The largest Indaptus Therapeutics buyer in Q2 2025 was Bank of America, an estimated $315 added.
  • The largest Indaptus Therapeutics seller in Q2 2025 was Vanguard Group, an estimated $141K sold.

Based on aggregated 13F filings for Q2 2025.